What’s Crimean-Congo haemorrhagic fever and how it spreads
The Crimean-Congo haemorrhagic fever has made an appearance in Gujarat after three years.
A 75-year-old woman was killed in Gujarat in a case of Crimean-Congo haemorrhagic fever. The disease has made an appearance in Gujarat after three years. Sukhiben Meniya from Jamdi village in Gujarat’s Surendranagar district died at the Ahmedabad Municipal Corporation-run Sardar Vallabbhai Patel (SCP) Hospital around midnight on Sunday.

Here’s an explainer on Crimean-Congo fever
A zoonotic viral disease transmitted from animals to humans by a tick that kills. It has a fatality rate of up to 30% of those infected.
Human to human infection
Occurs when contaminated blood, body fluids and waste of patients with the disease comes into contact with broken skin or mucous membranes, such as mouth, nose or eyelids, of another person.
At risk
People in the livestock industry, such as agricultural workers, slaughterhouse workers and veterinarians are at higher risk.
Origin
First described in Crimea (former USSR) in 1944. The disease is widespread in many countries in Africa, Europe, Middle East and Central Asia.
Incubation period
Usually five to six days after contact with infected blood or tissues, but can extend up to 13 days.
Outbreaks
India: First confirmed case was reported during a nosocomial— infections caught in hospitals, outbreak in Ahmadabad, Gujarat, in January 2011.
Subsequent outbreaks
During 2012–2015, cases were reported from the states of Gujarat and Rajasthan. Cases were documented from 6 districts of Gujarat (Ahmedabad, Amreli, Patan, Surendranagar, Kutch, and Aravalli) and 3 districts of Rajasthan (Sirohi, Jodhpur, and Jaisalmer). One case was also reported from Uttar Pradesh.
Last case
In 2016, a farmer died of the fever in Ahmedabad, Gujarat.
Symptoms
Sudden onset of fever, muscle ache, dizziness, neck pain and stiffness, backache, headache, sore eyes and sensitivity to light. There may also be nausea, vomiting, diarrhoea, abdominal pain and sore throat. In severe cases sharp mood swings and confusion.
Treatment
The patient is usually provided supportive care to manage symptoms.
Vaccine
No vaccine is currently available for human use.
ABOUT THE AUTHORRhythma KaulRhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

E-Paper


